| CAT No.BT-EBV-272 |
| Epstein-Barr virus (HHV-4) Early Antigen Recombinant, EBV EA, 500ug |
Applications
EBV-Ea antigen is suitable for ELISA and Western blots, excellent antigen for detection of HHV-4 (EBV) with minimal specificity problems.
Description
The E.Coli derived 35.5 kDa recombinant protein contains the HHV-4 Early Antigen Type D, C-terminus regions amino acids 306-390.
Formulation
50mM Tris-HCl, 10mM glutation, 60mM NaCl, 0.5% sarcosyl and 50% glycerol.
EBV-Ea was purified by proprietary chromatographic technique.
Purity
EBV-Ea protein is >95% pure as determined by 10% PAGE (coomassie staining).
Specificity
Immunoreactive with sera of EBV-infected individuals.
Stability
Five years frozen. One month in solution at room temperature.
Storage
EBV-Ea protein is shipped at ambient temperature. Upon arrival, Store at -20¡ãC.
Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
